Latest Insider Transactions at Marinus Pharmaceuticals, Inc. (MRNS)
This section provides a real-time view of insider transactions for Marinus Pharmaceuticals, Inc. (MRNS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MARINUS PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MARINUS PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 10
2024
|
Timothy M Mayleben |
SELL
Bona fide gift
|
Indirect |
8,300
-17.23%
|
-
|
|
Aug 05
2024
|
Scott Braunstein CHAIRMAN AND CEO |
SELL
Open market or private sale
|
Direct |
12,145
-3.91%
|
$12,145
$1.13 P/Share
|
|
Aug 05
2024
|
Joseph Hulihan CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,828
-6.23%
|
$4,828
$1.13 P/Share
|
|
Aug 05
2024
|
Martha E Manning SVP, GEN. COUNSEL & CORP. SEC. |
SELL
Open market or private sale
|
Direct |
3,621
-5.67%
|
$3,621
$1.13 P/Share
|
|
Aug 05
2024
|
Christina Shafer CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,820
-5.36%
|
$3,820
$1.14 P/Share
|
|
Aug 05
2024
|
Steven Pfanstiel CFO AND COO |
SELL
Open market or private sale
|
Direct |
4,657
-5.52%
|
$4,657
$1.13 P/Share
|
|
Jun 18
2024
|
Marvin Johnson |
BUY
Grant, award, or other acquisition
|
Direct |
2,300
+14.02%
|
-
|
|
Jun 18
2024
|
Sara Nochur |
BUY
Grant, award, or other acquisition
|
Direct |
2,300
+14.79%
|
-
|
|
Jun 18
2024
|
Timothy M Mayleben |
BUY
Grant, award, or other acquisition
|
Direct |
2,300
+8.62%
|
-
|
|
Jun 18
2024
|
Sarah B. Noonberg |
BUY
Grant, award, or other acquisition
|
Direct |
2,300
+14.02%
|
-
|
|
Jun 18
2024
|
Christine Berni Silverstein |
BUY
Grant, award, or other acquisition
|
Direct |
2,300
+14.02%
|
-
|
|
Jun 18
2024
|
Scott Braunstein CHAIRMAN AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
37,300
+10.71%
|
-
|
|
Jun 18
2024
|
Steven Pfanstiel CFO AND COO |
BUY
Grant, award, or other acquisition
|
Direct |
12,733
+13.1%
|
-
|
|
Jun 18
2024
|
Joseph Hulihan CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
10,918
+12.34%
|
-
|
|
Jun 18
2024
|
Martha E Manning SVP, GEN. COUNSEL & CORP. SEC. |
BUY
Grant, award, or other acquisition
|
Direct |
10,918
+14.6%
|
-
|
|
Jun 18
2024
|
Christina Shafer CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
10,918
+13.29%
|
-
|
|
Jun 18
2024
|
Charles Austin |
BUY
Grant, award, or other acquisition
|
Direct |
2,300
+15.89%
|
-
|
|
Jun 18
2024
|
Elan Ezickson |
BUY
Grant, award, or other acquisition
|
Direct |
2,300
+15.54%
|
-
|
|
Jun 18
2024
|
Seth H. Z. Fischer |
BUY
Grant, award, or other acquisition
|
Direct |
2,300
+15.11%
|
-
|
|
Mar 27
2024
|
Scott Braunstein CHAIRMAN AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+15.46%
|
$200,000
$4.28 P/Share
|
|
Feb 20
2024
|
Martha E Manning SVP, GEN. COUNSEL & CORP. SEC. |
SELL
Open market or private sale
|
Direct |
1,894
-3.45%
|
$17,046
$9.57 P/Share
|
|
Feb 20
2024
|
Christina Shafer CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,153
-3.45%
|
$19,377
$9.56 P/Share
|
|
Feb 16
2024
|
Scott Braunstein CHAIRMAN AND CEO |
SELL
Open market or private sale
|
Direct |
11,850
-5.03%
|
$106,650
$9.94 P/Share
|
|
Feb 16
2024
|
Steven Pfanstiel CFO AND COO |
SELL
Open market or private sale
|
Direct |
3,092
-4.13%
|
$27,828
$9.97 P/Share
|
|
Feb 16
2024
|
Joseph Hulihan CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,814
-4.05%
|
$25,326
$9.98 P/Share
|
|
Jan 18
2024
|
Seth H. Z. Fischer |
BUY
Grant, award, or other acquisition
|
Direct |
4,600
+30.21%
|
-
|
|
Jan 18
2024
|
Elan Ezickson |
BUY
Grant, award, or other acquisition
|
Direct |
4,600
+31.08%
|
-
|
|
Jan 18
2024
|
Christine Berni Silverstein |
BUY
Grant, award, or other acquisition
|
Direct |
4,600
+28.05%
|
-
|
|
Jan 18
2024
|
Marvin Johnson |
BUY
Grant, award, or other acquisition
|
Direct |
4,600
+28.05%
|
-
|
|
Jan 18
2024
|
Sarah B. Noonberg |
BUY
Grant, award, or other acquisition
|
Direct |
4,600
+28.05%
|
-
|
|
Jan 18
2024
|
Steven Pfanstiel CFO AND COO |
BUY
Grant, award, or other acquisition
|
Direct |
25,465
+25.4%
|
-
|
|
Jan 18
2024
|
Joseph Hulihan CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
21,835
+23.92%
|
-
|
|
Jan 18
2024
|
Martha E Manning SVP, GEN. COUNSEL & CORP. SEC. |
BUY
Grant, award, or other acquisition
|
Direct |
21,835
+28.47%
|
-
|
|
Jan 18
2024
|
Christina Shafer CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
21,835
+25.9%
|
-
|
|
Jan 18
2024
|
Timothy M Mayleben |
BUY
Grant, award, or other acquisition
|
Direct |
4,600
+17.24%
|
-
|
|
Jan 18
2024
|
Charles Austin |
BUY
Grant, award, or other acquisition
|
Direct |
4,600
+31.77%
|
-
|
|
Jan 18
2024
|
Sara Nochur |
BUY
Grant, award, or other acquisition
|
Direct |
4,600
+29.58%
|
-
|
|
Jan 18
2024
|
Scott Braunstein CHAIRMAN AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
74,600
+24.07%
|
-
|
|
Aug 08
2023
|
Joseph Hulihan CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
13
-0.03%
|
$104
$8.93 P/Share
|
|
Aug 08
2023
|
Martha E Manning SVP, GEN. COUNSEL & CORP. SEC. |
SELL
Open market or private sale
|
Direct |
11
-0.03%
|
$88
$8.93 P/Share
|
|
Aug 08
2023
|
Steven Pfanstiel CFO AND COO |
SELL
Open market or private sale
|
Direct |
14
-0.03%
|
$112
$8.93 P/Share
|
|
Aug 08
2023
|
Scott Braunstein CHAIRMAN AND CEO |
SELL
Open market or private sale
|
Direct |
30
-0.02%
|
$240
$8.94 P/Share
|
|
Aug 08
2023
|
Christina Shafer CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
11
-0.03%
|
$88
$8.93 P/Share
|
|
Aug 07
2023
|
Joseph Hulihan CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,889
-5.72%
|
$26,001
$9.55 P/Share
|
|
Aug 07
2023
|
Martha E Manning SVP, GEN. COUNSEL & CORP. SEC. |
SELL
Open market or private sale
|
Direct |
2,169
-6.16%
|
$19,521
$9.54 P/Share
|
|
Aug 07
2023
|
Steven Pfanstiel CFO AND COO |
SELL
Open market or private sale
|
Direct |
2,790
-5.35%
|
$25,110
$9.54 P/Share
|
|
Aug 07
2023
|
Scott Braunstein CHAIRMAN AND CEO |
SELL
Open market or private sale
|
Direct |
6,413
-3.84%
|
$57,717
$9.55 P/Share
|
|
Aug 07
2023
|
Christina Shafer CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,385
-5.54%
|
$21,465
$9.52 P/Share
|
|
May 16
2023
|
Sarah B. Noonberg |
BUY
Grant, award, or other acquisition
|
Direct |
7,200
+50.0%
|
-
|
|
Apr 17
2023
|
Marvin Johnson |
BUY
Grant, award, or other acquisition
|
Direct |
7,200
+50.0%
|
-
|